Rambus Other Income (Expense) increased by 7.7% to $6.87M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 53.4%, from $4.48M to $6.87M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 116.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$302.00K | $54.00K | -$1.11M | -$74.03M | $2.39M | -$13.48M | $0.00 | $1.54M | $1.86M | $2.36M | $27.76M | $4.22M | $4.03M | $4.34M | $4.44M | $4.48M | $4.85M | $6.03M | $6.38M | $6.87M |
| QoQ Change | — | +117.9% | <-999% | <-999% | +103.2% | -664.1% | +100.0% | — | +20.8% | +26.8% | >999% | -84.8% | -4.5% | +7.7% | +2.4% | +0.8% | +8.2% | +24.5% | +5.8% | +7.7% |
| YoY Change | — | — | — | — | +891.4% | <-999% | +100.0% | +102.1% | -22.2% | +117.5% | — | +174.1% | +116.6% | +84.0% | -84.0% | +6.1% | +20.3% | +39.0% | +43.6% | +53.4% |